Enterprise Value

-71.52M

Cash

183.9M

Avg Qtr Burn

-31.11M

Short % of Float

16.38%

Insider Ownership

48.95%

Institutional Own.

46.26%

Qtr Updated

12/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Posoleucel Details
BK virus, Kidney transplantation

Phase 2

Update

Posoleucel Details
Epstein-Barr virus, Human herpesvirus 6, BK virus, Adenovirus, Cytomegalovirus

Failed

Discontinued

Posoleucel Details
Virus-associated hemorrhagic cystitis , Adenovirus

Failed

Discontinued

ALVR106 Details
Respiratory syncytial virus, Influenza, Human metapneumovirus, Parainfluenza virus

Failed

Discontinued

Failed

Discontinued